Research regarding GLP-1 drugs and alcohol will likey include evaluating the relationships between the drugs, NMDA Glutmate Receptors and Heat Shock Proteins.
https://t.co/vczgCMMD3Z
https://t.co/cIt5yF3lJt
This prescribing strategy, more likely than not ,will also require dosing frequency less than daily to obtain the best defense against development of tolerance for maintaining the anti-inflammatory benefits that you are seeking.
You are unlikely to receive support from pharmaceutical companies, that this type of prescribing strategy may be benefical, for obvious marketing reasons.
Typically prescribers are unlikely to be supportive of what will be viewed as a signifcant deviation of general practice of care.
Hopefully, hybrid classical AI plus quantum computing may provide answers to low dose, low frequency prescribing to minimize development of tolerance to beneficial effects with long term use.
https://t.co/Cf4hBBryBc
Centanafadine, another "me to drug", now being marketed as a new class of ADHD medication.
It is an amphetamine, or amphetamine -like drug.
This marketing is similar to the the stimulant amphetamine-like Bupropion, except that Buproprion is marketed as an antidepressant.
This is an example of pharmaceutical marketing.
https://t.co/nDKiOQGxsp
Centanafadine, another "me to drug", now being marketed as a new class of ADHD medication.
It is an amphetamine, or amphetamine -like drug.
This marketing is similar to the the stimulant amphetamine-like Bupropion, except that Buproprion is marketed as an antidepressant.
This is an example of pharmaceutical marketing.
https://t.co/nDKiOQGxsp
Adverse drug withdrawal events,( terminology typically used for issues with stopping prescription medications such as antipsychotic or antidepressant medications), have overlapping features with acute alcohol, cocaine, cannabis, opioid, etc withdrawal- hyperexcitable neurotoxic nmda glutamate activity and issues with heat shock proteins.
Therefore, in theory and in clinical practice prescription drug discontinuation can be treated in a similar fashion as acute alcohol and illicit drug withdrawal, by targeting nmda glutamate hyperactivity and modulating heat shock proteins, with a 15 day or less detox taper.
Adverse drug withdrawal events,( terminology typically used for issues with stopping prescription medications such as antipsychotic or antidepressant medications), have overlapping features with acute alcohol, cocaine, cannabis, opioid, etc withdrawal- hyperexcitable neurotoxic nmda glutamate activity and issues with heat shock proteins.
Therefore, in theory and in clinical practice prescription drug discontinuation can be treated in a similar fashion as acute alcohol and illicit drug withdrawal, by targeting nmda glutamate hyperactivity and modulating heat shock proteins, with a 15 day or less detox taper.